Biossance™ Launches The Detoxifier ─ A Breakthrough,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Biossance™ Launches The Detoxifier ─ A Breakthrough, Innovative Modeling Mask

EMERYVILLE, Calif., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Biossance™, the pioneer of sustainable beauty through biotechnology from Amyris, Inc. (Nasdaq: AMRS ), today launched The Detoxifier, an innovative, new modeling mask for the face. This mask gently detoxifies and deeply hydrates the face, while calming and soothing the skin with squalane.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...29043cc834

This single-use, peel off modeling mask is the latest in a full line-up of products from Biossance that embodies the brand’s philosophy of providing consumers with safe and sustainable skin care products with well-vetted, high performance ingredients:

  • 100% plant-derived squalane: Instantly hydrates, leaves skin soft and smooth
  • Alginate (marine algae): Removes toxins from the skin’s surface, restores hydration
  • Zinc Gluconate: Exfoliates and detoxifies, deep cleans and tightens pores, reduces oiliness, calms skin, and reduces redness
  • Allantoin: Quenches dry, chapped skin, relieves irritation, gives skin a soft, smooth and healthy appearance.

“I really love the performance of Biossance products on my clients, who trust me to carefully choose cosmetic products that are safe and offer substantial skin benefits. The Detoxifier is a great biodegradable alternative to sheet masks that delivers results,” said Katey Denno, an A-list celebrity makeup artist known for her extensive knowledge of green beauty. “With the full line of products from the Biossance brand, I always know that whatever I reach for to meet my clients’ specific needs will perform and be made from a nontoxic, sustainable source.”

“Our Biossance product portfolio continues to deliver the brand’s No Compromise® commitment of delivering products that are safe, sustainable and best in class performance. Consumers are rewarding us with record sales performance for our brand almost every week this quarter,” said Caroline Hadfield, Amyris’s Senior Vice President, Personal Care.

The Detoxifier is now available at biossance.com along with a full line of products. Each Biossance product is free of harmful ingredients that are commonly used in other brands by using only the good, none of the bad (for more information about Biossance’s high standards please visit the Biossance Blacklist page).

About Biossance

Biossance™ pioneered sustainable 100% plant-based squalane to replenish your skin and restore your biological beauty. The squalane-based brand was created in response to the prevalent use of squalane derived from sharks as an emollient in cosmetic products, creating devastating environmental impact. We’ve designed our line of squalane-based products to empower and inform you, so you can trust that what you are putting on your skin is safe. We won’t compromise, so we hand-select the most effective ingredients and avoid those that are potentially harmful to you or the planet. The full Biossance skin care and beauty collection can be found at http://biossance.com .

About Amyris

Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com .

Amyris, the Amyris logo, Biossance, and No Compromise are trademarks or registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners.

The photo is also available at Newscom, www.newscom.com , and via AP PhotoExpress.

Elle Communications Megan Noller 424-634-8370 Megan@ellecomm.com Amyris, Inc. Peter DeNardo Director, Investor Relations and Corporate Communications (510) 740-7481 investor@amyris.com pr@amyris.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 501

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 130

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 564

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 707

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 299

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 112

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 496

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading